Table 2. Factors affecting the severity of side effects associated with COVID-19 vaccination.
Variables | Did the symptoms affect your work? | p-value | ||||
No | Yes | |||||
No | % | No | % | |||
Age group | Less than 50 years old | 353 | 58.4% | 251 | 41.6% | 0.438 |
More than 50 years old | 30 | 65.2% | 16 | 34.8% | ||
Gender | Male | 270 | 63.2% | 157 | 36.8% | 0.000* |
Female | 86 | 46.5% | 99 | 53.5% | ||
Past history of COVID-19 infection | No | 245 | 59.5% | 167 | 40.5% | 0.352 |
Yes | 111 | 55.5% | 89 | 44.5% | ||
Type of vaccine received | Not vaccinated | 1 | 100.0% | 0 | 0.0% | 0.014* |
AstraZeneca | 90 | 48.9% | 94 | 51.1% | ||
Pfizer | 250 | 62.5% | 150 | 37.5% | ||
Both | 15 | 55.6% | 12 | 44.4% | ||
Number of doses | One dose | 59 | 57.3% | 44 | 42.7% | 0.832 |
Two doses | 295 | 58.4% | 210 | 41.6% | ||
Blood type | Type A | 83 | 51.60% | 78 | 48.40% | 0.241 |
Type B | 77 | 58.80% | 54 | 41.20% | ||
Type O | 157 | 61.60% | 98 | 38.40% | ||
Type AB | 39 | 60.00% | 26 | 40.00% |